Our sense of vision enables us like no other to independently and freely do what we want. It is very difficult for most people to lose it: They must completely adjust themselves to learn how to compensate the loss through hearing, touching and auxiliary means. But today, we are already able to treat many diseases that threaten our vision. Research of how to treat other diseases is merely just beginning. Therefore, we take a look into today’s and tomorrow’s ophthalmology in our Topic of the Month.
Achromatopsia is a rare hereditary visual disorder. Along with total color blindness, patients most notably suffer from reduced visual acuity and increased sensitivity to light and glare. Within the scope of an international consortium, scientists from various specialty areas from Tübingen, Munich and New York succeeded in developing a gene therapy for patients with achromatopsia.